Inmune Bio, Inc.INMB

時価総額

$2億

PER

	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日
REVENUE	-	10,916	0	0
General and administrative	6	6	9	9
Research and development	3	6	21	17
Total operating expenses	8	12	29	26
LOSS FROM OPERATIONS	-7,756,001	-12,227,676	-29	-26
Other expense, net	-	-	-	1
Total other expense, net	-	-	-1	-1
NET LOSS	-7,678,313	-12,099,159	-30	-27
Net loss per common share – basic and diluted (in Dollars per share)	-	-	-	-1.52
NET LOSS	-7,678,313	-12,099,159	-30	-27
Other comprehensive loss – foreign currency translation	-15,044	19,223	-0	-1
Total comprehensive loss	-7,693,357	-12,079,936	-30	-28